CDT Equity Shares to Reverse Split on Monday, July 20th (NASDAQ:CDT)

CDT Equity Inc. (NASDAQ:CDT) shares are scheduled to reverse split on Monday, July 20th. The 1-10 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, July 19th.

CDT Equity Stock Performance

Shares of CDT stock traded up $0.00 on Thursday, reaching $0.35. The stock had a trading volume of 888,099 shares, compared to its average volume of 19,030,332. The stock has a market cap of $1.73 million, a P/E ratio of -0.00 and a beta of 1.49. CDT Equity has a 1 year low of $0.30 and a 1 year high of $461.54. The company has a 50 day simple moving average of $0.92 and a 200 day simple moving average of $12.33.

CDT Equity (NASDAQ:CDT) last issued its quarterly earnings data on Wednesday, July 15th. The company reported ($5.56) EPS for the quarter.

Analysts Set New Price Targets

CDT has been the subject of several research reports. Wall Street Zen lowered shares of CDT Equity to a “strong sell” rating in a research report on Saturday, June 27th. Weiss Ratings reiterated a “sell (e+)” rating on shares of CDT Equity in a research note on Wednesday, June 24th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.

CDT Equity Company Profile

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.